Innate Pharma
Clinical-stage biotech developing immunotherapies for cancer using the innate immune system.
IPH | PA
Overview
Corporate Details
- ISIN(s):
- FR0010331421 (+1 more)
- LEI:
- 9695002Y8420ZB8HJE29
- Country:
- France
- Address:
- 117 AVENUE DE LUMINY, 13009 MARSEILLE
- Website:
- http://www.innate-pharma.com/
- Sector:
- Manufacturing
Description
Innate Pharma is a clinical-stage, oncology-focused biotechnology company that develops immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system, particularly Natural Killer (NK) cells, to create novel treatments. Its innovative pipeline is composed of antibody-based therapeutics, including first-in-class monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific NK cell engagers based on its proprietary ANKET® platform. Key clinical programs include lacutamab (anti-KIR3DL2), monalizumab (anti-NKG2A) in partnership with AstraZeneca, and a portfolio of NK cell engagers targeting various hematological malignancies and solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2010-01-08 18:00 |
Half-year report on INNATE PHARMA’S liquidity contract with NATIXIS SECURITIES
|
English | 35.5 KB | ||
| 2009-12-23 19:23 |
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce son calendrier f…
|
French | 34.6 KB | ||
| 2009-12-23 19:23 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces its financial and …
|
English | 34.6 KB | ||
| 2009-12-18 18:37 |
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) annonce aujourd’hui une l…
|
French | 42.7 KB | ||
| 2009-12-18 18:37 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces today a capital in…
|
English | 42.9 KB | ||
| 2009-12-07 06:50 |
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce aujourd’hui l’en…
|
French | 66.6 KB | ||
| 2009-12-07 06:50 |
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) provides today an overvie…
|
English | 64.5 KB | ||
| 2009-11-06 18:30 |
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) announces its turnover fo…
|
English | 40.5 KB | ||
| 2009-11-06 18:30 |
Innate Pharma SA annonce son chiffre d’affaires trimestriel au 30 septembre 200…
|
French | 41.6 KB | ||
| 2009-11-02 18:59 |
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) annonce avoir reçu l’auto…
|
French | 52.4 KB | ||
| 2009-11-02 18:59 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces that it has receiv…
|
English | 57.8 KB | ||
| 2009-09-21 06:50 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) reports Phase II clinical da…
|
English | 78.3 KB | ||
| 2009-09-21 06:50 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) présente des resultats clini…
|
French | 82.5 KB | ||
| 2009-09-18 18:10 |
L’Assemblée Générale d’Innate Pharma (Euronext Paris: FR0010331421 – IPH) a aut…
|
French | 45.0 KB | ||
| 2009-09-18 18:10 |
The General Meeting of Innate Pharma (Euronext Paris: FR0010331421 – IPH) has a…
|
English | 34.9 KB |
Automate Your Workflow. Get a real-time feed of all Innate Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Innate Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Innate Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Buy | 6,000 | N/A |
| 2024-01-02 | N/A | Other | Buy | 20,000 | N/A |
Peer Companies
